THURSDAY, JUNE 09, 2022

Thursday, Room 1

08:40-09:52 Scientific Session 1

Moderators: C. Beigelman-Aubry, Lausanne/CH; G. Chassagnon, Paris/FR
08:40 Automatic evaluation of Bronchial Parameters using a combined Open-Source Artificial Intelligence and Optimal-Surface Graph-Cut Method
I. Dudurych, Groningen/NL
08:48 Deep learning-based air trapping quantification analysing structure-function relationships in children with cystic fibrosis using paired inspiratory-expiratory ultra-low dose CT
S.M. Muller, Heidelberg/DE
08:56 Deep learning-based quantification of perfusion abnormalities in chest MRI for cystic fibrosis
F. Ringwald, Heidelberg/DE
09:04 Performance of an AI Powered Algorithm to Detect Pulmonary Embolism on Virtual Monochromatic CTPA Images
E. Langius-Wiffen, Zwolle/NL
09:12 Clinical evaluation of a content-based image retrieval system for diagnosing diffuse parenchymal lung disease in pulmonary CTs
H. Prosch, Vienna/AT
09:20 Reproducibility of Pulmonary Magnetic Resonance Angiography in Adults with Muco-Obstructive Pulmonary Disease
L. Wucherpfennig, Heidelberg/DE
09:28 Look-locker based T1 relaxometry and high-resolution T2 in the evaluation of lung lesions: A unicentric prospective study
M. Koenigkam-Santos, Ribeirao Preto/BR
09:36 Impact of photon-counting CT (PCCT) in the evaluation of interstitial lung disease (ILD): Preliminary experience in 29 patients
M. Remy-Jardin, Lille/FR
09:44 Chest CT angiography (CTA) in daily routine with a photon-counting CT equipment: Preliminary experience
M. Remy-Jardin, Lille/FR

 

09:40-10:00 Coffee Break

 

10:00-10:15 Opening Session

Welcome from the 2020-2022 congress president
F. Gleeson, Oxford/UK

 

10:15-10:20 Break

 

10:20-12:00 Lung Cancer I

Moderators: F. Gleeson, Oxford/UK; M. Prokop, Nijmegen/NL
10:20 Atypical CT appearances of lung cancer
I. Hartmann, Rotterdam/NL
10:45 Staging the mediastinum for lung cancer – Arcane and novel methods
H. Prosch, Vienna/AT
11:10 The Lung Cancer Diagnostic Pathway – Are delays significant
D. Baldwin, Nottingham/UK
11:35 State of the art lung biopsy
S. Padley, London/UK

 

12:00-12:05 Break

12:05-13:05 Industry sponsored lunch symposium

Moderator: P. Douek, Lyon/FR
12:05 State-of-the-Art Thoracic CT: The Value of High Concentration Iodinated Contrast
G. Milanese, Parma/IT
12:35 Dual Energy CT and beyond: Where are we headed?
P. Douek, Lyon/FR

13:05-13:20 Break

 

13:20-15:20 Lung Cancer II

Moderators: P. Beddy, Dublin/IE; A. Snoeckx, Edegem/BE
13:20 Imaging of post surgical appearances
P. Beddy, Dublin/IE
13:50 Ablation of lung tumours – Complications and outcomes
A.R. Larici, Rome/IT
14:20 Immunotherapy for lung cancer and imaging appearances
M-P. Revel, Paris/FR
14:50 CT and genetic mutations in lung cancer
J. Dinkel, Munich/DE

 

15:20-15:50 Coffee Break

 

15:50-16:20 Industry sponsored symposium “AI in Lung Cancer Screening: Where are we?”

Panel Discussion
A. Nair, London/UK; M-P. Revel, Paris/FR; A. Snoeckx, Edegem/BE

16:20-16:30 Break

 

16:30-18:10 Thoracic CT – Miscellaneous patterns and diseases

Moderators: F. Molinari, Tourcoing/FR; N. Screaton, Cambridge/UK
16:30 The Tree in Bud pattern – State of the art interpretation and diagnosis
J. Verschakelen, Leuven/BE
16:55 Role of CT scan in clinical management of sarcoidosis
L-P. Ho, Oxford/UK
17:20 Hypersensitivity pneumonitis – New approaches to diagnosis
C. Ridge, London/UK
17:45 Pulmonary Hypertension and the right ventricle on CT
L. Meijboom, Amsterdam/NL

Thursday, Room 2

08:40-09:44 Scientific Session 2

Moderators: I. Hartmann, Rotterdam/NL; S. Padley, London/UK
08:40 Post-COVID-19 1-year follow-up: Radiologic and pathologic correlation
D. Cozzi, Florence/IT
08:48 Pulmonary arteries enlargement in pulmonary embolism related to COVID-19 pneumonia: A single-center experience
A. Grimaldi, Rome/IT
08:56 Minimal Clinically Important Difference (MCID) for quantitative analysis of progressive pulmonary fibrosis on High Resolution Computed Tomography (HRCT)
G. Cicchetti, Rome/IT
09:04 Assessing The Proportion of PA vs AP Chest X-rays Performed Amongst Emegency Department and Inpatients at a District General Hospital
Z. Nisar, Stevenage/UK
09:12 Radiology-Pathology Correlation in Coatomer Subunit Alpha (COPA) Syndrome with Novel Finding of Pulmonary Lymphangiectasia
S. Ghosh, Cleveland/US
09:20 How often pleural appendages resemble pleural tumours on chest radiographs?
A. Villanueva, Redhill/UK
09:28 Pre-operative cardiothoracic ratio’s prognostic value in adult cardiac surgery under cardiopulmonary bypass
H. Ramdani, Rabat/MA
09:36 Long-term follow-up of pulmonary arterial circulation after hospitalization for SARS-CoV-2 pneumonia : Dual-energy CT angiographic study in 79 patients
M. Remy-Jardin, Lille/FR

 

09:40-10:00 Coffee Break
10:00-10:20 Break

 

10:20-12:00 Airways

Moderators: A.R. Larici, Rome/IT; D. Manos, Halifax/CA
10:20 Interventional treatments for COPD
A. Moore, Oxford/UK
10:45 Relapsing polychondritis and mimics
G. Chassagnon, Paris/FR
11:10 Novel treatments for COPD and role of imaging
J. Babar, Thriplow/UK
11:35 HRCT and bronchiectasis
S. Desai, London/UK

 

12:00-13:20 Break

 

13:20-15:20 Pulmonary Vascular

Moderators: R. Benamore, Oxford/UK; S. Copley, London/UK
13:20 Dual energy in pulmonary vascular disease
M. Remy-Jardin, Lille/FR
13:50 Who to refer for pulmonary endarterectomy?
N. Screaton, Cambridge/UK
14:20 Recent advances in CTPA
C. Schaefer-Prokop, Amersfoort/NL
14:50 Imaging pulmonary haemorrhage
E. Castañer González, Sabadell/ES

 

15:20-15:50 Coffee Break
15:50-16:30 Break

 

16:30-18:10 Mediastinum and Pleura

Moderators: J. Babar, Thriplow/UK; A. Farchione, Rome/IT
16:30 Management of pleural effusions
J. Wrightson, Oxford/UK
16:55 Diagnosis and staging of thymoma
B. Ghaye, Brussels/BE
17:20 Mesothelioma and pleural surgery
T. Frauenfelder, Zurich/CH
17:45 Diffuse pleural thickening – Diagnosis and clinical significance
R. Benamore, Oxford/UK

 

 

FRIDAY, JUNE 10, 2022

Friday, Room 1

08:15-08:55 ESTI General Assembly
08:55-09:00 Break

 

09:00-10:00 Scientific Session 3

Moderators: A. Dubbeldam, Nieuwrode/BE; A. Snoeckx, Edegem/BE
09:00 Improving Image Resolution in 3-D Lung MRI Images by Combining Two Orthogonal Scans Using Super Resolution Reconstruction
J. Grolig, Heidelberg/DE
09:07 AI detection of normal chest radiographs in clinical practice
S. Schalekamp, Nijmegen/NL
09:14 Radiomics in pulmonary neuroendocrine tumours (NETs)
D. Cozzi, Florence/IT
09:21 Anterior mediastinal masses – Can CT morphologic and radiomic features predict pathologic classification?
M. Mayoral, New York/US
09:28 Prediction of disease severity in COVID-19 patients identifies predictive disease patterns in lung CT
J. Pan, Vienna/AT
09:35 Automatic quantification of COVID-19 viral pneumonia in chest computed tomography images using an artificial intelligence algorithm developed at a Brazilian university hospital
M. Koenigkam-Santos, Ribeirao Preto/BR
09:42 Evaluation of radiologists’ performance compared to a deep learning algorithm for the detection of thoracic abnormalities on chest X-ray
S. Bennani, Paris/FR
09:49 Discussion

 

10:00-10:30 Coffee Break

 

10:30-12:00 Automated Evaluation in Thoracic Imaging

Moderators: F. Gleeson, Oxford/UK; M. Wielpütz, Heidelberg/DE
10:30 The basics of Artificial Intelligence
B. van Ginneken, Nijmegen/NL
10:55 The work needed to implement the use of AI in CXR interpretation
A.P. Parkar, Bergen/NO
11:20 AI in nodule classification
C. Jacobs, Nijmegen/NL
11:45 AI in Interstitial Lung Disease
J. Jacob, London/UK

 

12:00-12:15 Break

 

12:15-13:15 Industry sponsored lunch symposium “Latest developments in lung cancer screening”

Moderator: C. Schaefer-Prokop, Amersfoort/NL
12:15 Lung Cancer Screening in a nutshell
C. Schaefer-Prokop, Amersfoort/NL
12:35 Technological aspects of CT for Lung Cancer Screening
M. Prokop, Nijmegen/NL
12:55 Filtration and Subtraction in Lung CT
R. Bull, Bournemouth/UK

 

13:15-13:30 Break

 

13:30-15:30 Acute Imaging

Moderators: A.R. Larici, Rome/IT; M-P. Revel, Paris/FR
13:30 Imaging Blunt Thoracic Trauma
B. Hussain, Rotterdam/NL
14:00 Incidental findings in thoracic trauma scans
E. Dick, London/UK
14:30 Pulmonary embolism in pregnancy
A. Beale, Swindon/UK
15:00 Haemothorax and cardiac trauma imaging
M. Brink, Nijmegen/NL

 

15:30-16:00 Coffee Break

 

15:60-16:30 Industry sponsored symposium “Advancing the Early Diagnosis of Lung Cancer: Impact of Structured Reporting in IPN Management”

Moderator: H. Prosch, Vienna/AT
15:30 Welcome, Introductions and Overview
H. Prosch, Vienna/AT
15:35 IPN Management
• How IPN management can drive a stage shift from late- to early-stage lung cancer and its impact on lung cancer survival trends
• Best practices for structured reporting in IPN management
D.S. Dyer, Denver/US
15:50 Q&A
H. Prosch, Vienna/AT
15:55 Summary and Closing Remarks
H. Prosch, Vienna/AT

 

16:30-18:30 ESTI meets respiratory medicine – A joint session with ERS

Moderator: F. Gleeson, Oxford/UK; S. Padley, London/UK
16:00 LDCT LC screening: Further work-up of high-risk nodule findings

G. Hardavella, Athens/GR
16:20 Thoracic Ultrasound
T. Frauenfelder, Zurich/CH
16:40 ESTI Film Quiz
F. Gleeson, Oxford/UK; S. Padley, London/UK

Friday, Room 2

09:00-10:08 Scientific Session 4

Moderators: G. Aviram, Tel Aviv/IL; A. Nair, London/UK
09:00 The HUNCHEST project – Lung cancer screening pilot studies in Hungary
A. Kerpel-Fronius, Budapest/HU
09:08 [68Ga]Ga-DOTA-(RGD)2 PET/CT imaging of endothelial activation in COVID-19 patients
E. van Genugten, Nijmegen/NL
09:16 Pre-treatment metastatic site-specific 18F-FDG PET markers are associated with clinical outcomes in patients with NSCLC receiving immunotherapy
D. Kifjak, Vienna/AT
09:24 CT characteristics of solid lung adenocarcinomas with low FDG uptake
S. Schalekamp, Nijmegen/NL
09:32 Diagnostic impact of quantitative dual-energy computed tomography perfusion imaging for the assessment of subsegmental chronic pulmonary thromboembolism
K. Hekimoglu, Ankara/TR
09:40 Maximising radiologist adherence to nodule management protocols in lung screening – A comparison of three radiologist support tools
E. Bartlett, London/UK
09:48 Association between Large Arteries Diameter and Heart Function in Subjects free of Cardiovascular Diseases
R. von Krüchten, Freiburg/DE
09:56 Dual-energy CT lung perfusion in systemic sclerosis: Preliminary experience in 101 patients
M. Remy-Jardin, Lille/FR

 

10:00-10:30 Coffee Break

 

10:30-12:00 Screening

Moderators: A. Devaraj, London/UK; M. Silva, Parma/IT
10:30 3 challenges – Lessions learned from Italy
M. Silva, Parma/IT
10:55 False negatives in lung cancer screening
M. Prokop, Nijmegen/NL
11:20 Subsolid nodules – When to intervene?
M-P. Revel, Paris/FR
11:45 Discussion

 

12:00-13:30 Break

 

13:30-15:30 Lung Cancer III – ESTI meets CSTR

Moderators: C. Dennie, Ottawa/CA; F. Gleeson, Oxford/UK
13:30 PET-CT in Lung Cancer
A. Scarsbrook, York/UK
14:00 The Indeterminate Pulmonary Nodule: Providing More Definitive Characterization of Benign Etiology
D. Manos, Halifax/CA
14:30 Lung Cancer pre- and post radiotherapy
H. Prosch, Vienna/AT
15:00 Lung Cancer Survivorship: Follow-up of the Lung Cancer Patient after Curative Intent Therapy
J. Taylor, Montreal, Quebec/CA

 

 

SATURDAY, JUNE 11, 2022

Saturday, Room 1

08:00-09:45 ESTI meets ESCR

Moderators: J. Biederer, Heidelberg/DE; C. Peebles, Southampton/UK
08:00 Noncardiac findings on cardiac CT
R. Vliegenthart, Groningen/NL
08:25 Cardiac calcifications: What do they tell us?
F. Pontana, Lille/FR
08:50 Why chest radiologists should be involved in coronary CTA
J. Bremerich, Basel/CH
09:15 How to do coronary CTA in 20 minutes
R. Vliegenthart, Groningen/NL
09:40 Discussion

 

09:45-10:15 Coffee Break

 

10:15-10:45 Industry sponsored symposium

Moderator: D. Rosewarne, Wolverhampton/UK
Why does AI sometimes fail? The underrecognised effects of hidden stratification
C. Jones, Brisbane/AU

 

10:45-12:00 Techniques

Moderators: G. Aviram, Tel Aviv/IL; A. Nair, London/UK
10:45 Applications of Photon-counting CT
C. Xie, Oxford/UK
11:10 Understanding xenon MRI
J. Wild, Sheffield/UK
11:35 MRI of the airways
J. Biederer, Heidelberg/DE

 

12:00-12:15 Break

 

12:15-13:15 Industry sponsored lunch symposium “How Deep Learning and GSI help you overcome your clinical challenges?”

Moderator: F. Gleeson, Oxford/UK
12:15 Ultra Low Dose Chest Imaging in Pediatrics
S. Tschauner, Graz/AT
12:45 Enhancing Contrast in Thoracic CT – Benefits of spectral reconstructions and software
P. Sommer, Rigshospitalet/DK

 

13:15-13:30 Break

 

13:30-15:30 Lung Nodule

Moderators: A.R. Larici, Rome/IT; C. Schaefer-Prokop, Amersfoort/NL
13:30 Measuring nodule size – Methods and outcomes
A. Nair, London/UK
14:00 Importance of morphological assessment
A. Farchione, Rome/IT
14:30 Incidental nodules: How to reduce over diagnosis and investigation?
M. Silva, Parma/IT
15:00 Benign lung tumours
A. Snoeckx, Edegem/BE

 

15:30-15:45 Break

 

15:45-16:45 Honorary Membership & Awards

Moderator: F. Gleeson, Oxford/UK
15:45 Honorary Lecture “Lung cancer screening: The next steps”
M. Prokop, Nijmegen/NL
16:05 Honorary Lecture “Why choose Radiology”
M-P. Revel, Paris/FR
16:25 Awards & Presentation of ESTI 2023
J. Biederer, Heidelberg/DE; F. Gleeson, Oxford/UK

Saturday, Room 2

08:00-09:45 ILD

Moderators: H. Prosch, Vienna/AT; J. Verschakelen, Leuven/BE
08:00 Incidental/subclinical lung abnormalities
N. Sverzellati, Parma/IT
08:25 NSIP revisited
A. Devaraj, London/UK
08:50 Antisynthetase and related connective tissue diseases – HRCT appearances
P-Y. Brillet, Bobigny/FR
09:15 Smoking related ILD
A. Oikonomou, Toronto/CA
09:40 Discussion

 

09:45-10:15 Coffee Break

 

10:45-12:00 Infection and immunosupressed patient imaging

Moderator: A. Oikonomou, Toronto/CA
10:45 Imaging in fungal infection
T. Franquet, Barcelona/ES
11:10 TB: What’s new and what’s old?
I. Tyurin, Moscow/RU
11:35 Acute and long term Covid imaging
W. de Wever, Leuven/BE

 

13:00-13:48 ESTI meets KSTR (oral presentations)

Moderators: A.P. Parkar, Bergen/NO; W. Kwon, KR
13:00 Deep learning-based survival prediction model for COPD patients using chest radiographs: Development and validation
C.M. Park, Seoul/KR
13:08 Quantitative CT Image Matching Analysis of Multiscale Airway and Lung Structure-Function Responses to Bronchodilator in Asthma
C. Lee, Seoul/KR
13:16 Quantitation of HRCT Findings Using a Texture-Based Automated System for Relation With Clinical Manifestations of IPF-Patients
J.S. Park, Bucheon/KR
13:24 Predictive CT Features of Visceral Pleural Invasion by Lung Cancer That Abut the Pleura
S.R. Kang, Iksan/KR
13:32 Association of 10-year Mortality and Incidental Abnormalities on Screening Thoracic Computed Tomography: A Single-center Study
J.E. Lee, Gwangju/KR
13:40 Lateral Chest Radiograph: “Spine sign” and More
E.S. Lee, Seoul/KR
13:48 Prediction of Total Lung Capacity Using Chest Radiographs: Validation of Technical Performance and Clinical Utility
S.H. Yoon, Seoul/KR

X